BackPTC Therapeutics Overview
PTC Therapeutics Inc

PTC Therapeutics Target Price

Analysts' 12-month price predictions for PTCT.

Get informed when a big investor buys or sells

+ Follow

Share Price

$78.06

Average Target Price

$93.0019.1% upside

4 analysts in the last 4 months

High: $108 | Low: $85

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-07RBC Capital$858.9% upsideOpen
2026-05-27Jefferies$858.9% upsideOpen
2026-05-08Morgan StanleyJudah Frommer$9420.4% upsideOpen
2026-04-10Raymond JamesTiago Fauth$10838.4% upsideOpen
2026-02-23Morgan Stanley$9217.9% upsideOpen
2026-02-23BarclaysEliana Merle$12053.7% upsideOpen
2026-02-20RBC CapitalBrian Abrahams$825% upsideOpen
2026-02-20Wells Fargo$8610.2% upsideOpen
2026-01-27Barclays$11952.4% upsideOpen
2026-01-08Morgan Stanley$9015.3% upsideOpen
2025-12-01RBC Capital$9116.6% upsideOpen
2025-11-05Goldman Sachs$5035.9% downsideOpen
2025-11-05Wells FargoTiago Fauth$9319.1% upsideOpen
2025-11-05BarclaysGena Wang$6812.9% downsideOpen
2025-10-28JefferiesKelly Shi$771.4% downsideOpen
2025-08-08Robert W. BairdJoel Beatty$7010.3% downsideOpen
2025-05-07Robert W. BairdJoel Beatty$6615.4% downsideOpen
2025-01-07RBC CapitalBrian Abrahams$5825.7% downsideOpen
2024-11-27Robert W. BairdJoel Beatty$5233.4% downsideOpen
2024-10-11Morgan StanleyJeffrey Hung$4542.4% downsideOpen
2024-08-26UBSColin Bristow$4739.8% downsideOpen
2024-07-12Morgan StanleyJeffrey Hung$3259% downsideOpen
2024-05-20Goldman SachsPaul Choi$3259% downsideOpen
2024-05-20JefferiesKelly Shi$4641.1% downsideOpen
2024-04-26Morgan StanleyJeffrey Hung$3061.6% downsideOpen
2022-12-14Goldman Sachs$3555.2% downsideOpen
2022-06-23RBC CapitalBrian Abrahams$4641.1% downsideOpen
2022-04-05Cantor FitzgeraldKristen Kluska$6319.3% downsideOpen
2021-08-31UBSColin Bristow$4542.4% downsideOpen